InflaRx NVSTU:IF0 +0.72%30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:IF0 with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, InflaRx NV ranks worse than 98.23% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. InflaRx NV's Free Cash Flow for the
three
months ended in Mar. 2026 was €-7.40 Mil. InflaRx NV's Revenue for the
three
months ended in Mar. 2026 was €0.00 Mil. Therefore, InflaRx NV's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for InflaRx NV's FCF Margin % or its related term are showing as below:
STU:IF0'
s FCF Margin % Range Over the Past 10 Years
Min: -122020.59 Med: -59889.86 Max: -29249.43
Current: -99327.59
During the past 11 years, the highest FCF Margin % of InflaRx NV was -29249.43%. The lowest was -122020.59%. And the median was -59889.86%.
STU:IF0's FCF Margin % is ranked worse than 98.23% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs STU:IF0: -99327.59
InflaRx NV FCF Margin % Related Terms
InflaRx NV FCF Margin % Historical Data
* Premium members only.
The historical data trend for InflaRx NV's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:IF0 vs IRD, NAUT, RGNX: FCF Margin % Comparison
For the Biotechnology subindustry, InflaRx NV's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InflaRx NV FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, InflaRx NV's FCF Margin % distribution charts can be found below:
* The bar in red indicates where InflaRx NV's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InflaRx NV (STU:IF0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on InflaRx NV and its competitors. According to the industry distribution chart, InflaRx NV ranks #942 out of 959 companies in the Biotechnology industry, placing it in the top 98.2%.
Is InflaRx NV's FCF Margin % too high?
InflaRx NV's current FCF Margin % is 0.00%. Based on the distribution chart, InflaRx NV ranks #942 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, InflaRx NV has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's FCF Margin % compare to IRD and NAUT?
According to the Biotechnology industry distribution chart, InflaRx NV ranks #942 out of 959 companies for FCF Margin %. This places InflaRx NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on InflaRx NV and its competitors. InflaRx NV's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (STU:IF0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. InflaRx NV's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For InflaRx NV (STU:IF0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
30GF Score
Get the complete analysis for STU:IF0
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IF0 has been successfully added to your 
